The determination of oxalic acid, oxamic acid, and oxamide in a drug substance by ion-exclusion chromatography.
Oxalic acid, oxamic acid and oxamide are potential impurities in some active pharmaceutical ingredients (API). The retention and separation of oxalic and oxamic acids are particularly challenging using conventional reversed-phase HPLC due to their high polarity. An ion-exclusion chromatography (IEC) method has been shown to provide good separation and sensitivity for the three oxalate-related impurities in a hydrophobic API matrix. The method uses a Dionex IonPac ICE-ASI column with 95/5 (v/v) 0.1% sulfuric acid/acetonitrile as the mobile phase and UV detection at 205 nm. Development and validation of this method are described.
Yang
L
L
Lilly Research Laboratories, Eli Lilly and Company, Lafayette, IN 47902, USA. yang_liu@lilly.com
Liu
L
L
Olsen
B A
BA
Nussbaum
M A
MA
D002850:Chromatography, Gel / Q000379:methods*; D002851:Chromatography, High Pressure Liquid / Q000379:methods*; D004340:Drug Contamination; D016014:Linear Models; D019815:Oxalic Acid / Q000032:analysis*; D010072:Oxamic Acid / Q000031:analogs & derivatives* / Q000032:analysis*; D019163:Reducing Agents / Q000032:analysis*; D012680:Sensitivity and Specificity
D019163:Reducing Agents; D019815:Oxalic Acid; D010072:Oxamic Acid; C008728:oxamide